All articles by Srivani Venna

  1. FDA approves Aleor’s Diclofenac sodium topical solution

    The US Food and Drug Administration (FDA) has granted tentative approval for Aleor Dermaceuticals’ Diclofenac sodium topical solution USP, 2%…
    Read More…

    2 Dec
  2. AstraZeneca secures FDA priority review for SCLC drug Imfinzi

    English-Swedish pharmaceutical and biopharmaceutical company AstraZeneca has secured the US Food and Drug Administration (FDA) priority review for Imfinzi (durvalumab)…
    Read More…

    2 Dec
  3. Incyte secures FDA priority review for bile duct cancer drug

    US-based biopharmaceutical company Incyte has announced that the US Food and Drug Administration (FDA) accepted for priority review its New…
    Read More…

    29 Nov
  4. Neuraxpharm expands Southern Europe operations with Portugal unit

    European speciality pharmaceutical company Neuraxpharm Group has announced the launch of Neuraxpharm Portugal as part of an expansion of its…
    Read More…

    29 Nov
  5. ImmuPharma signs agreement with Avion for Lupuzor

    UK-based pharmaceutical company ImmuPharma has signed a licensing and development agreement with US-based Avion Pharmaceuticals for Lupuzor, a peptide therapeutic…
    Read More…

    29 Nov
  6. Health Canada approves Boehringer’s Ofev to slow SSc-ILD

    Boehringer Ingelheim (Canada) has secured approval from Health Canada for its Ofev (nintedanib) to slow the rate of decline in…
    Read More…

    28 Nov
  7. P&G completes Merck’s Consumer Health unit acquisition for $3.8bn

    Procter & Gamble (P&G) has completed its acquisition of Merck’s Consumer Health business in a €3.4bn ($3.8bn) deal. The acquisition…
    Read More…

    3 Dec
  8. US scientists reveal new gene therapy for Parkinson’s disease

    Scientists from Feinstein Institute for Medical Research in the US have revealed that a gene therapy called AAV2-GAD for Parkinson’s…
    Read More…

    30 Nov
  9. Innovent and Hutchison to test sintilimab and fruquintinib combination

    Innovent Biologics (Suzhou) has entered into a global collaboration agreement to evaluate the safety of its sintilimab in combination with…
    Read More…

    30 Nov
  10. Women with pregnancy losses are at risk of cardiovascular disease

    Research from the UK’s University of Cambridge and the University of North Carolina in the US has revealed women have…
    Read More…

    30 Nov
Close
Close
Close

Go Top